CurvaFix has developed the CurvaFix® IM Implant, a groundbreaking intramedullary device specifically designed to address pelvic fractures by conforming to the natural curvature of the pelvis. This innovative implant is the first of its kind in 30 years, offering a significant advancement over traditional treatment methods that utilize straight screws and bone plates. The CurvaFix implant is flexible during implantation, allowing it to navigate challenging pelvic anatomies, and once positioned, it locks into a rigid state to provide strong and stable fixation. This design not only enhances the force-to-failure ratio but also minimizes the risk of pullout, making it a superior option for patients suffering from pelvic fractures.

The technology behind the CurvaFix IM Implant includes a patented locking mechanism that transforms the implant from a flexible to a rigid state, ensuring effective stabilization of the fracture. The implant features four internal cables that facilitate its flexibility during insertion, and once locked, it distributes forces evenly across the bone, promoting better healing outcomes. The procedure is minimally invasive, typically completed in about 20 minutes, and is performed under standard fluoroscopy, which contributes to reduced surgical time and costs. Overall, the CurvaFix IM Implant represents a significant leap forward in orthopedic trauma care, particularly for elderly patients with fragility fractures, by enabling quicker recovery and potentially avoiding the need for nursing home care.

United States

CurvaFix is developing implantable products to improve fracture repair in curved bones. The company is focusing on Fragility Fractures of the Pelvis (FFP) and high-impact pelvic fractures. The CurvaFix® IM Implant is the only intramedullary device capable of following the natural bone shape and filling the space within curved bones such as the pelvis.





CurvaFix

Company Details